"alpha-Fetoproteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The first alpha-globulins to appear in mammalian sera during FETAL DEVELOPMENT and the dominant serum proteins in early embryonic life.
| Descriptor ID |
D000509
|
| MeSH Number(s) |
D12.776.124.790.106.092 D12.776.320.525.500 D12.776.377.228.500 D12.776.377.715.085.092 D23.101.140.050
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "alpha-Fetoproteins".
Below are MeSH descriptors whose meaning is more specific than "alpha-Fetoproteins".
This graph shows the total number of publications written about "alpha-Fetoproteins" by people in this website by year, and whether "alpha-Fetoproteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 1 | 2 |
| 1997 | 0 | 4 | 4 |
| 1998 | 0 | 1 | 1 |
| 1999 | 2 | 3 | 5 |
| 2000 | 3 | 1 | 4 |
| 2001 | 1 | 1 | 2 |
| 2002 | 0 | 3 | 3 |
| 2003 | 0 | 4 | 4 |
| 2004 | 1 | 3 | 4 |
| 2005 | 4 | 3 | 7 |
| 2006 | 1 | 2 | 3 |
| 2007 | 0 | 1 | 1 |
| 2008 | 2 | 3 | 5 |
| 2009 | 3 | 4 | 7 |
| 2010 | 2 | 5 | 7 |
| 2011 | 3 | 3 | 6 |
| 2012 | 2 | 3 | 5 |
| 2013 | 1 | 2 | 3 |
| 2014 | 2 | 2 | 4 |
| 2015 | 5 | 2 | 7 |
| 2016 | 0 | 8 | 8 |
| 2017 | 1 | 1 | 2 |
| 2018 | 3 | 1 | 4 |
| 2019 | 0 | 2 | 2 |
| 2020 | 1 | 1 | 2 |
| 2021 | 3 | 2 | 5 |
| 2022 | 0 | 8 | 8 |
| 2023 | 0 | 5 | 5 |
| 2024 | 2 | 2 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "alpha-Fetoproteins" by people in Profiles.
-
National Liver Cancer Screening Trial (TRACER) study protocol. Hepatol Commun. 2024 Nov 01; 8(11).
-
Limited Role of MSAFP Screening for Prenatal Omphalocele Detection. J Ultrasound Med. 2024 Dec; 43(12):2303-2310.
-
Impact of microscopic deposits of yolk sac tumor on recurrence of mature sacrococcygeal teratoma. J Surg Oncol. 2024 Sep; 130(3):569-573.
-
Hepatocellular Carcinoma Screening in a Contemporary Cohort of At-Risk Patients. JAMA Netw Open. 2024 Apr 01; 7(4):e248755.
-
Comparative Clinicopathologic and Genomic Analysis of Hepatocellular Neoplasm, Not Otherwise Specified, and Hepatoblastoma. Mod Pathol. 2024 Feb; 37(2):100385.
-
Unusual Initial Presentation of Hepatocellular Carcinoma as a Clavicular Head Mass. Oncology (Williston Park). 2023 08 08; 37(8):335-338.
-
Incidence and Risk Factors for Hepatocellular Carcinoma in Cirrhosis: The Multicenter Hepatocellular Carcinoma Early Detection Strategy (HEDS) Study. Gastroenterology. 2023 10; 165(4):1053-1063.e6.
-
Vincristine/irinotecan/temsirolimus upfront window treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 Study Committee. Pediatr Blood Cancer. 2023 07; 70(7):e30365.
-
Recall patterns and risk of primary liver cancer for subcentimeter ultrasound liver observations: a multicenter study. Hepatol Commun. 2023 03 01; 7(3).
-
Blood-based biomarkers for hepatocellular carcinoma screening: Approaching the end of the ultrasound era? J Hepatol. 2023 01; 78(1):207-216.